CHENGDU, China , Oct. 19, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3 OptiTROP-Lung04 trial of the Company's...
Hence then, the article about positive results from phase 3 optitrop lung04 trial of sacituzumab tirumotecan presented at esmo presidential symposium and simultaneously published in nejm was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM )
Also on site :
- Spain Face Croatia Today: Kickoff Time and Broadcast Details
- 1978 Rolling Stones Classic, Ranked Among ‘Greatest Keith Richards Songs,’ Was Recorded in 5 Days With No Sleep
- Lindsay Clancy Returns to Court Today, 3 Weeks After Her Mistrial